Asia
China National Medicines' Attributable Profit Up 3% in Q1
China National Medicines' (SHA:600511) attributable profit rose 3.3% to 474.3 million yuan in the first quarter from 459 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.Earnings per share at the pharmaceutical company increased 3.3% to 0.6286 yuan from 0.6084 yuan in the prior-year period.Operating income grew 6.6% year over year to 13.6 billion yuan from 12.7 billion yuan.
SHA:600511
